News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ImmuPharma plc (IMM.L) Swings to H1 Profit After Cephalon, Inc. (CEPH) Deal



9/29/2009 7:13:49 AM

Bookmark and Share

Reuters -- British drug developer ImmuPharma said on Tuesday it swung to a first-half profit after licensing out a key drug to a U.S. partner.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES